The abstract is read at the publisher; the summary is JClub's.
FlahyRecovery subtypes tumor microenvironments into Hot, Cold, and Intermediate using 1275 immune signaling genes, achieving 79% sensitivity, 89% specificity, and one-vs-rest AUC 0.93 in N=1337.
- Why it matters: Tumor microenvironment immune signaling is hard to characterize with existing methods, limiting reliable predictions of therapeutic response and prognosis for precision oncology decisions.
- What they did: The approach annotated 7424 tumor specimens across 14 cancers into three immune subtypes, then trained a supervised machine learning classifier to assign new specimens using expression of 1275 immune signaling genes.
- The result: In the multi-tumor validation cohort (N=1337), Elevated Immunity is linked to prolonged survival and immunotherapy response, while Suppressed Immunity is linked to treatment resistance and need for combination therapy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.